Acute myocardial infarction
|
0.060 |
Biomarker
|
disease |
BEFREE |
3 weeks post AMI, data showed increase in capillary density (p < 0.01) and reduction in infarct sizes (p < 0.05) in Bac-NP(Ang1) compared to Bac(Ang1), NP(Ang1) and control groups due to enhanced myocardial Ang-1 expression at peri-infarct regions (1.65 times higher than Bac(Ang1)).
|
21840594 |
2011 |
Bronchopulmonary Dysplasia
|
0.010 |
Biomarker
|
disease |
BEFREE |
BPD is associated with a shift from traditional angiogenic growth factors (vascular endothelial growth factor, angiopoietin-1) to alternative regulators such as endoglin, which may contribute to BPD-associated microvascular dysangiogenesis.
|
18420967 |
2008 |
Borderline Personality Disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
BPD is associated with a shift from traditional angiogenic growth factors (vascular endothelial growth factor, angiopoietin-1) to alternative regulators such as endoglin, which may contribute to BPD-associated microvascular dysangiogenesis.
|
18420967 |
2008 |
Diabetes Mellitus
|
0.080 |
Biomarker
|
group |
BEFREE |
Diabetes-induced nephrin phosphorylation was also reduced in mice with angiopoietin-1 repletion.
|
24009238 |
2014 |
Diabetes
|
0.060 |
Biomarker
|
disease |
BEFREE |
Diabetes-induced nephrin phosphorylation was also reduced in mice with angiopoietin-1 repletion.
|
24009238 |
2014 |
Hypertensive disease
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Hypertension was induced in adult Sprague-Dawley rats by infusion of aldosterone (ALDO; 0.75 μg/hour) for 4 weeks with or without co-treatment of Ang1-7 (1 mg/kg/day).Untreated rats served as controls.
|
30715105 |
2019 |
Malignant neoplasm of breast
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Ang1 was then overexpressed in a human breast cancer cell line (MCF-7) on its own and in conjunction with FGF1, an angiogenic factor shown to be able to increase the tumorigenicity of MCF-7 cells.
|
11027428 |
2000 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Ang1 was then overexpressed in a human breast cancer cell line (MCF-7) on its own and in conjunction with FGF1, an angiogenic factor shown to be able to increase the tumorigenicity of MCF-7 cells.
|
11027428 |
2000 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Ang1 expression was found in a few astrocytes scattered in the tumor at all stages of astrocytoma progression.
|
11304469 |
2001 |
Astrocytoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Ang1 expression was found in a few astrocytes scattered in the tumor at all stages of astrocytoma progression.
|
11304469 |
2001 |
Childhood Astrocytoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Ang1 expression was found in a few astrocytes scattered in the tumor at all stages of astrocytoma progression.
|
11304469 |
2001 |
Malignant neoplasm of breast
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
|
11309342 |
2001 |
Breast Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
|
11309342 |
2001 |
Rheumatoid Arthritis
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Ang-1 was the most highly expressed ligand in late stage RA synovial fibroblasts; however, in chronic inflamed synovial tissue, Ang-2 was predominant and was expressed at strikingly high levels (70 to 120-fold increase).
|
11838839 |
2002 |
Arthritis
|
0.040 |
Biomarker
|
disease |
BEFREE |
Ang-1 may therefore be an important regulator of angiogenesis in inflammatory arthritis.
|
12525377 |
2003 |
Focal nodular hyperplasia of liver
|
0.020 |
Biomarker
|
disease |
BEFREE |
Ang-1 protein was detected on Western blot of FNH and expressed by endothelial cells of dystrophic vessels and sinusoids as shown by immunohistochemistry.
|
12612904 |
2003 |
Focal Nodular Hyperplasia
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Ang-1 protein was detected on Western blot of FNH and expressed by endothelial cells of dystrophic vessels and sinusoids as shown by immunohistochemistry.
|
12612904 |
2003 |
Liver carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Ang-1 was expressed in 68% of HCCs, whereas Ang-2 was expressed in 81%, and was significantly higher in poorly differentiated HCCs characterised by high vascularity (p = 0.02), and in tumours with a peliotic change (p = 0.02).
|
14600132 |
2003 |
Liver carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Angiopoietin-1 and -2 cDNA were subcloned into the pcDNA3 vector and subsequently transfected into a human SMMC7721 hepatocellular carcinoma (HCC) cell line without detectable angiopoietin gene expression before transfection.
|
14607656 |
2003 |
Tumor Angiogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Angiopoietin-1 and Angiopoietin-2 have been shown to be involved in tumor angiogenesis.
|
15094228 |
2004 |
Liver diseases
|
0.030 |
Biomarker
|
group |
BEFREE |
Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.
|
15331413 |
2004 |
Chronic myocardial ischemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Angiopoietin-1 promotes functional neovascularization that relieves ischemia by improving regional reperfusion in a swine chronic myocardial ischemia model.
|
16547766 |
2006 |
Chondrosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Ang-1 presented as a low-level transcript with slightly elevated levels in chondrosarcomas (P < .05).
|
16565972 |
2006 |
Malignant neoplasm of stomach
|
0.030 |
Biomarker
|
disease |
BEFREE |
Ang-1 and Tie2 positivity correlated with advanced gastric cancers (p<0.05) and larger cancers had higher positive rates of Ang-1, Ang-2, and Tie2 mRNA expression (p<0.001, =0.010 and =0.039, respectively).
|
16614513 |
2006 |
Rheumatoid Arthritis
|
0.060 |
Biomarker
|
disease |
BEFREE |
Ang-1 stimulates the ERK/MAPK and PI 3-kinase/Akt pathways cooperatively, but in a manner independent of each other, to directly potentiate synovium overgrowth and joint destruction in RA.
|
17599743 |
2007 |